Therefore, it is necessary to further study whether PPIH, like Arg-1, can be used in combination with common markers such as HepPar-1 and glypican-3 to improve the specificity of HCC diagnosis and provide scientific basis for the hierarchical diagnosis and treatment of HCC. This evidence concerns the gene GPC3 and hepatocellular carcinoma.